TELA
HealthcareTELA Bio Inc
Live · NASDAQ · May 9, Close
What's Moving TELA Today?
No stock-specific AI insight has been generated for TELA yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
TELA News
20 articles- BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·May 7, 2026
- TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 RevenuesYahoo Finance·Apr 30, 2026
- TELA Bio to Announce First Quarter 2026 Financial ResultsYahoo Finance·Apr 21, 2026
- TELA Bio, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 25, 2026
- TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ...Yahoo Finance·Mar 25, 2026
- TELA Bio (TELA) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 24, 2026
- TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue EstimatesYahoo Finance·Mar 24, 2026
- TELA Bio Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 24, 2026
- Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top EstimatesYahoo Finance·Mar 19, 2026
- TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 10, 2026
- Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass EstimatesYahoo Finance·Mar 2, 2026
- Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat EstimatesYahoo Finance·Feb 26, 2026
- TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare ConferenceYahoo Finance·Nov 19, 2025
- TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ...Yahoo Finance·Nov 14, 2025
- TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 13, 2025
- TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded WarrantsYahoo Finance·Nov 13, 2025
- TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit FacilityYahoo Finance·Nov 13, 2025
- Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance·Nov 12, 2025
- Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue EstimatesYahoo Finance·Nov 6, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About TELA Bio Inc
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.